October 2019 - Page 88 of 319

NASDAQ Companies - October 25, 2019

Mid Penn Bancorp, Inc. Reports Third Quarter 2019 Earnings and Declares Quarterly Dividend

MILLERSBURG, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — Mid Penn Bancorp, Inc. (“Mid Penn”) (NASDAQ: MPB), the parent company of […]

NASDAQ Companies - October 25, 2019

Cabaletta Bio Announces Pricing of Initial Public Offering

PHILADELPHIA, Oct. 25, 2019 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical stage biotechnology company focused on the […]

TSX News - October 25, 2019

Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates […]

NASDAQ Companies - October 25, 2019

Turnkey Enterprise LED Lighting and Controls Provider Orion Hosts Q2’20 Call on Wednesday, November 6th at 10:00 am ET

MANITOWOC, Wis., Oct. 25, 2019 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of turnkey […]

NASDAQ Companies - October 25, 2019

Pacira to Report Third Quarter 2019 Financial Results on Thursday November 7, 2019

PARSIPPANY, N.J., Oct. 25, 2019 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third […]

NASDAQ Companies - October 25, 2019

Ocugen to Host Conference Call on Friday, November 8 at 8:30 a.m. ET to Discuss Third Quarter Results and Recent Business Highlights

MALVERN, Pa., Oct. 25, 2019 (GLOBE NEWSWIRE) — Ocugen, Inc., (NASDAQ: OCGN), a clinical stage biopharmaceutical company focused on discovering, […]

NASDAQ Companies - October 25, 2019

MacroGenics Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer

Rockville, MD, Oct. 25, 2019 (GLOBE NEWSWIRE) —MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing […]